Faculty profile

Colin Collins

ResearcherUrologic SciencesUniversity of British Columbia

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of British Columbia directory, so their courses may be missing. Find their university profile.

Colin Collins

Researcher

Urologic Sciences

Health Sciences

University of British Columbia

Vancouver, British Columbia, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
22 publications in the last five years, latest in 2026.
Principal investigator on 4 research grants (4 CIHR), most recently in 2020.
Supervisor on 1 trainee award (1 CIHR), most recently in 2016.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Prostate Cancer Biomarkers Metastasis Biopsies Metabolomics Neuroendocrine Transdifferentiation Patient Derived Xenografts Single Cell Rna-Sequencing

Latest papers

Well-differentiated papillary mesothelial tumour: histologic, molecular and genetic features support a benign clonal neoplasm despite diffuse peritoneal involvement.
Histopathology · 2026
CAR-T cell-derived exosomes and cancer immunotherapy: advancing production and delivery through biofabrication.
Biofabrication · 2026
Microfluidic platforms for precision delivery of therapeutic cells in regenerative and personalized medicine.
Advanced drug delivery reviews · 2026

All 52 publications

Latest funding

Derisking the Development of VPC-25959 Derivatives as Novel MCT4 Inhibitors for Clinical Trials in Patients with Advanced Glycolytic Cancers
CIHR · 2026 · Co-investigator
$1,912,500
PROX1 Drives Cell Lineage Reprogramming in Neuroendocrine Prostate Cancer
CIHR · 2025 · Co-investigator
$1,166,625
CHD7 as a key upstream chromatin regulator driving NEPC development and aggressiveness
CIHR · 2025 · Co-investigator
$100,000

All 14 grants and awards

52 publications.

Well-differentiated papillary mesothelial tumour: histologic, molecular and genetic features support a benign clonal neoplasm despite diffuse peritoneal involvement.

Leduc C, Rahimi K, Mercier F, Haegert A, Volik S, LeBihan S, Collins C, Churg A

Histopathology2026

DOI: 10.1111/his.70080 PMID: 41424264

CAR-T cell-derived exosomes and cancer immunotherapy: advancing production and delivery through biofabrication.

Razzaghi M, Karimi MH, Hadjati J, Collins C, Akbari M

Biofabrication2026

DOI: 10.1088/1758-5090/ae7b0b PMID: 42263750

Microfluidic platforms for precision delivery of therapeutic cells in regenerative and personalized medicine.

Mirlohi MS, Akar S, Yazdani K, Alizadeh Sardroud H, Fardindoost S, Taemeh MA, Achuthan M, Singh S, Tibbits G, Hadjati J, Collins C, Hoorfar M, Karimi MH, Akbari M

Advanced drug delivery reviews2026

DOI: 10.1016/j.addr.2026.115865 PMID: 41935637

Atrial Fibrillation Related Titin Truncation Is Associated With Atrial Myopathy in Patient-Derived Induced Pluripotent Stem Cell Disease Models

Huang K, Ashraf M, Rohani L, Luo Y, Sacayanan A, Huang H, Haegert A, Volik S, Sar F, LeBihan S

Circulation. Genomic and precision medicine20258 citations

DOI: 10.1161/circgen.123.004412

Corrigendum to "RNA Splicing of the BHC80 Gene Contributes to Neuroendocrine Prostate Cancer Progression" [Eur. Urol. 76(2) (2019) 157-166].

Li Y, Xie N, Chen R, Lee AR, Lovnicki J, Morrison EA, Fazli L, Zhang Q, Musselman CA, Wang Y, Huang J, Gleave ME, Collins C, Dong X

European urology2025

DOI: 10.1016/j.eururo.2025.04.022 PMID: 40340107

Longitudinal single-cell analysis reveals RUNX1T1 as an early driver in treatment-induced neuroendocrine transdifferentiation.

Ni Y, Lin D, Shi M, Lin YY, Xue H, Dong X, Liu L, Sar F, Wu R, Morova T, Haegert A, Bell R, Pang X, Classen A, Wang Y, Chen J, Volik S, Bihan SL, Lack N, Ong C, Wang G, Zeng H, Collins C, Wang Y

bioRxiv : the preprint server for biology2025

DOI: 10.1101/2025.05.14.653660 PMID: 40463134

scMUSCL: multi-source transfer learning for clustering scRNA-seq data.

Khoeini A, Sar F, Lin YY, Collins C, Ester M

Bioinformatics (Oxford, England)2025

DOI: 10.1093/bioinformatics/btaf137 PMID: 40152244

Exploring B7-H4's Role in Prostate Cancer Dormancy after Androgen Deprivation Therapy: Extracellular Matrix Interactions and Therapeutic Opportunities.

Kang N, Xue H, Wong NKY, Lin YY, Classen A, Wu R, Oo HZ, Dong X, Trinh A, Lin D, Daugaard M, Ong C, Collins C, Gleave M, Wang Y

Molecular cancer research : MCR2025

DOI: 10.1158/1541-7786.mcr-24-0958 PMID: 39776163

Spatial Transcriptomics in Human Cardiac Tissue.

Nguyen Q, Tung LW, Lin B, Sivakumar R, Sar F, Singhera G, Wang Y, Parker J, Le Bihan S, Singh A, M V Rossi F, Collins C, Bashir J, Laksman Z

International journal of molecular sciences2025

DOI: 10.3390/ijms26030995 PMID: 39940764

Distinct transcription factor interactions drive HOXB13 activity in different stages of prostate cancer.

Ersoy-Fazlioglu B, Lingadahalli S, Altintas UB, Cingoz A, Tekoglu E, Lok Yu IP, Dikbas M, Missaghimamaghani O, Yavuz K, Adomat H, Kulac I, Morova T, Xiao K, Gleave M, Fazli L, Cejas P, Cherkasov A, Zwart W, Haffner MC, Long HW, Collins C, Bagci-Onder T, Lack NA

Proceedings of the National Academy of Sciences of the United States of America2025

DOI: 10.1073/pnas.2500327122 PMID: 41343677

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mentionMention their CIHR grant from 2020

Subject: Prospective PhD student: Prostate Cancer Dear Professor Collins, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Well-differentiated papillary mesothelial tumour: histologic, molecular and genetic features support a benign clonal neoplasm despite diffuse peritoneal involvement." (2026), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "Uncovering early mediators of lineage plasticity and validation of a metabolic vulnerability in neuroendocrine prostate cancer" (2020), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]

Something wrong or missing on this profile? Suggest a correction

Colin Collins

Research

Latest papers

Latest funding

Well-differentiated papillary mesothelial tumour: histologic, molecular and genetic features support a benign clonal neoplasm despite diffuse peritoneal involvement.

CAR-T cell-derived exosomes and cancer immunotherapy: advancing production and delivery through biofabrication.

Microfluidic platforms for precision delivery of therapeutic cells in regenerative and personalized medicine.

Atrial Fibrillation Related Titin Truncation Is Associated With Atrial Myopathy in Patient-Derived Induced Pluripotent Stem Cell Disease Models

Corrigendum to "RNA Splicing of the BHC80 Gene Contributes to Neuroendocrine Prostate Cancer Progression" [Eur. Urol. 76(2) (2019) 157-166].

Longitudinal single-cell analysis reveals RUNX1T1 as an early driver in treatment-induced neuroendocrine transdifferentiation.

scMUSCL: multi-source transfer learning for clustering scRNA-seq data.

Exploring B7-H4's Role in Prostate Cancer Dormancy after Androgen Deprivation Therapy: Extracellular Matrix Interactions and Therapeutic Opportunities.

Spatial Transcriptomics in Human Cardiac Tissue.

Distinct transcription factor interactions drive HOXB13 activity in different stages of prostate cancer.

Frequent collaborators

Yuzhuo Wang

Martin Gleave

Xuesen Dong

Zachary Laksman

Colin Collins

Yu Wang

Amina Zoubeidi

Mads Daugaard

Ralph Buttyan

Christopher Ong

Wan Lam

Arnaud Droit

Mohsen Akbari

Gang Wang

Artem Cherkasov

Sohrab Shah

Mira Keyes

Michael Milosevic

Nathan Lack

Jeffrey Bacha

Calum Macaulay

Stanley Liu

Jason Roberts